Previously, he was a postdoc in the Computational Biology Group at MIT and the Broad Institute, building models to predict the mechanism of action of genetic variants associated with type 2 diabetes, total cholesterol and Alzheimer’s Disease. He completed his PhD in Computer Science at the University of Toronto under Quaid Morris, where his research focused on developing models to deconvolute gene expression profiles of heterogeneous cell populations, in order to improve personalized medicine in cancer. He also holds a MSc in Biochemistry from the University of Toronto, as well as an undergraduate degree in Computer Science from the University of Waterloo.